Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 15/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.49 |
| ▸ | DRD2 | P14416 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7250772 | 1.00 | ADRB3 (0.49) | ADRB3ADRB1ADRB2DRD2PGR | |
| SCHEMBL7042586 | 0.82 | ADRB3 (0.55) | ADRB3ADRB1ADRB2PTGS1SLC6A2 | |
| SCHEMBL7042485 | 0.81 | ADRB3 (0.52) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7042681 | 0.80 | ADRB3 (0.45) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7042476 | 0.80 | ADRB3 (0.54) | ADRB3ADRB1ADRB2 | |
| SCHEMBL7610387 | 0.78 | ADRB2 (0.46) | ADRB3ADRB1ADRB2DRD2PGR | |
| SCHEMBL7041021 | 0.77 | ADRB3 (0.71) | ADRB3ADRB1ADRB2CYP2D6PTGS1 | |
| Hydrochloric Acid SCHEMBL7039782 | 0.76 | ADRB3 (0.70) | ADRB3ADRB1ADRB2CYP2D6PTGS1 | |
| Hydrochloric Acid SCHEMBL7248953 | 0.76 | ADRB3 (0.70) | ADRB3ADRB1ADRB2CYP2D6PTGS1 | |
| Hydrochloric Acid SCHEMBL7040329 | 0.76 | ADRB3 (0.70) | ADRB3ADRB1ADRB2CYP2D6PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | XDH, ADH1A, ADRB1 | ADRB3 20/4885ADRB1 3/4885ADRB2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.